Search...
Features
Assets
Blog
Help
Learn
Get App
Login
Sign Up
Get App
Lonza
S$79.97
118
+S$0
+0%
Tuesday 20:00
1D
1W
1M
3M
1Y
5Y
Statistics
Day High
-
Day Low
-
52W High
79.97
52W Low
79.97
Volume
-
Avg. Volume
0
Mkt Cap
5.96B
P/E Ratio
-
Dividend Yield
3.73%
Dividend
2.98
Upcoming
25
JAN 25
Earnings
13
MAY 25
Dividend Ex
Estimated
15
MAY 25
Dividend Payment
Estimated
13
MAY 26
Dividend Ex
Estimated
15
MAY 26
Dividend Payment
Estimated
Dividends
3.73
%
Dividend Yield
May 24
S$2.98
May 24
S$2.98
May 23
S$2.61
May 23
S$2.61
May 22
S$2.1
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
15.55%
1Y Growth
14.27%
Earnings
25
Jul
Confirmed
Q4 2022
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
Q2 2024
0
2.71
5.42
8.13
Expected EPS
5.6460348
Actual EPS
7.808346
People Also Follow
This list is based on the watchlists of people on Stock Events who follow O6Z.SG. It's not an investment recommendation.
Alphabet
71357
GOOGL
Apple
62588
AAPL
Microsoft
58339
MSFT
Amazon
53786
AMZN
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Thermo Fisher Scientific
TMO
Mkt Cap
230.72B
Thermo Fisher Scientific offers similar biotechnology and pharmaceutical services, including contract manufacturing and development services, competing directly with Lonza's core business.
Danaher
DHR
Mkt Cap
194.51B
Danaher Corporation, through its Life Sciences segment, competes in the bioprocessing space, offering products and services that overlap with Lonza's offerings in pharmaceutical development and manufacturing.
Charles River Laboratories International
CRL
Mkt Cap
10.42B
Charles River Laboratories provides a range of preclinical and clinical laboratory services for the pharmaceutical, medical device, and biotechnology industries, competing with Lonza in contract development and manufacturing organization (CDMO) services.
IQVIA
IQV
Mkt Cap
43.68B
IQVIA offers extensive clinical research services, including biopharmaceutical development, which competes with Lonza's services in drug development and manufacturing.
Catalent
CTLT
Mkt Cap
10.78B
Catalent is a provider of delivery technologies, development, and manufacturing solutions for drugs, biologics, and consumer health products, directly competing with Lonza in drug development and delivery solutions.
West Pharmaceutical Services
WST
Mkt Cap
21.79B
West Pharmaceutical Services specializes in designing and manufacturing containment and delivery systems for injectable drugs and healthcare products, competing with Lonza in the pharmaceutical and biotech supply chain.
Bio-Rad Laboratories
BIO
Mkt Cap
9.08B
Bio-Rad Laboratories offers products and services in life science research and clinical diagnostics, competing with Lonza in the provision of specialized instruments and reagents for the pharmaceutical industry.
About
There is no Profile data available for O6Z.SI.
Show more...
CEO
Country
CH
ISIN
CH0013841017
WKN
000928619
Listings
MX
MX
LONN.MX
SW
CH
LONN.SW
SW
CH
LONNE.SW
OTCM
US
LZAGF
Add to Watchlist